<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1073754</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2023.1073754</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Optimisation of alpha-amylase inhibitor production in solid state fermentation</article-title>
<alt-title alt-title-type="left-running-head">Fatoki et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1073754">10.3389/fphar.2023.1073754</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fatoki</surname>
<given-names>O. A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2025624/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Onilude</surname>
<given-names>A. A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ekanola</surname>
<given-names>Y. A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akanbi</surname>
<given-names>C. T.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Biology</institution>, <institution>The Polytechnic</institution>, <addr-line>Ibadan</addr-line>, <country>Nigeria</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Microbiology</institution>, <institution>University of Ibadan</institution>, <addr-line>Ibadan</addr-line>, <country>Nigeria</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Food Science and Technology</institution>, <institution>Obafemi Awolowo University</institution>, <addr-line>Ile-Ife</addr-line>, <country>Nigeria</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/107209/overview">Teodorico Castro Ramalho</ext-link>, Universidade Federal de Lavras, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1275718/overview">Sadia Sultan</ext-link>, Universiti Teknologi MARA Puncak Alam, Malaysia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/723012/overview">Alexandre Alves De Castro</ext-link>, Universidade Federal de Lavras, Brazil</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: O. A. Fatoki, <email>fatoki.oladotun@polyibadan.edu.ng</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1073754</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>02</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Fatoki, Onilude, Ekanola and Akanbi.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Fatoki, Onilude, Ekanola and Akanbi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Though not a known producer of alpha-amylase inhibitor, the potential of <italic>Streptomyces xinghaiensis</italic> AAI-2 to produce this important metabolite was assessed and the process optimised in solid substrate using response surface methodology. The isolate was grown in an inoculum medium, inoculated into wheat bran and supplemented with a basal medium for production of alpha amylase inhibitor. Optimum conditions were determined by Response Surface Methodology. The extract was recovered using sodium phosphate buffer at refrigerated temperature and assay for the presence of alpha-amylase inhibitor was carried out by Dinitrosalicylic acid method. Based on the results of the experimental trials and iteration with those values, it was predicted that optimal pH for alpha-amylase inhibitor production using <italic>S. xinghaiensis</italic> in solid culture of wheat bran was pH 6.4&#x2013;6.9 while optimal moisture content and incubation time were predicted as 71%&#x2013;73% and 9&#x2013;12&#xa0;days respectively.</p>
</abstract>
<kwd-group>
<kwd>alpha-amylase inhibitor</kwd>
<kwd>optimisation</kwd>
<kwd>RSM</kwd>
<kwd>
<italic>Streptomyces</italic>
</kwd>
<kwd>solid state fermentation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Alpha-amylase inhibitors are glycoproteins that can inhibit starch hydrolysis by alpha-amylase. This hydrolysis yields simpler, less complex subunits by hydrolysing the &#x3b1;-1, 4 bonds of starch at its non-reducing end. Due to the presence and role of this enzyme in the digestive tract of some animals including man, alpha-amylase inhibitors (&#x3b1;AI) have been proposed to be useful in the regulation of the rate of digestion of starch. From its discovery by <xref ref-type="bibr" rid="B15">Marshall and Lauda (1975)</xref> as a source of an amylase inhibitor, white kidney bean (<italic>Phaseolus vulgaris</italic>) is arguably the most widely studied source of the alpha amylase inhibitor. Related research has involved purification and the elucidation of characteristics, application and clinical trials, expression of gene in competent microorganisms, uses as nutraceutical agent among others, including a more recent publication on the incorporation of <italic>P. vulgaris</italic> in yoghurt for the control of blood glucose in hyperglycemic mice <italic>via</italic> the modulation of microorganisms in the gastrointestinal tract (<xref ref-type="bibr" rid="B29">Wang et al., 2021</xref>). While numerous plant sources exist and have been identified, synthetic types including miglitol, acarbose, voglibose and indazoles also exist (<xref ref-type="bibr" rid="B4">DiNicolantonio et al., 2015</xref>; <xref ref-type="bibr" rid="B5">Garg et al., 2022</xref>). Submerged fermentation of filamentous bacteria of the genus <italic>Streptomyces</italic> has also yielded alpha-amylase inhibitors which have been variously characterized and applied (<xref ref-type="bibr" rid="B13">Manivasagan et al., 2015</xref>). The advantages associated with solid state fermentation include secretion of metabolites that are better adapted to numerous environmental conditions and applications (<xref ref-type="bibr" rid="B11">Leite et al., 2021</xref>). Furthermore, the process is considered cheaper, since the carbon and energy sources for microbial use are mostly agricultural wastes. Since the need for water is less, there is a consequent low effluent produced and a reduced need to use water treatment processes when done on an industrial scale (<xref ref-type="bibr" rid="B6">Holker and Lenz, 2005</xref>). The low water activity is thought to discourage the growth of contaminating yeast and bacteria thereby minimising the strict need for sterilisation, hence energy. The optimal conditions for production of &#x3b1;AI in solid production medium using actinomycetes was investigated.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Isolation and identification</title>
<p>Soil samples collected from 10&#xa0;cm depth of an area (7.44&#xb0;N, 3.89&#xb0;E) within the premises of University of Ibadan, Nigeria having active plant degradation was pre-treated by air drying for 24&#xa0;h. Further pre-treatment was done by subjecting a suspension of the pre-treated soil to heat at 70&#xb0;C for 15&#xa0;min and subsequently adding 1.5% phenol (v/v) to the soil suspension (Seong et al., 2001; <xref ref-type="bibr" rid="B25">Tiwari and Gupta, 2012</xref>). A ten-fold serial dilution of the soil suspension was done and 0.1&#xa0;mL of the diluted sample was inoculated in sterile starch casein nitrate agar (g/L): [starch (10), casein (0.3), KNO<sub>3</sub> (2.0), NaCl (2.0), K<sub>2</sub>HPO<sub>4</sub> (2.0), CaCO<sub>3</sub> (0.02), MgSO<sub>4</sub>.7H<sub>2</sub>O (0.05), FeSO<sub>4</sub>.7H<sub>2</sub>O (0.01), agar (15)] and supplemented with nystatin (50&#xa0;&#x3bc;g/mL) and nalidixic acid (20&#xa0;&#x3bc;g/mL) as antifungal and antibacterial agents respectively. The culture was incubated for 10&#xa0;days at 28&#xb0;C.</p>
<p>Isolates were characterised by observation of morphological characteristics, biochemical tests (<xref ref-type="bibr" rid="B18">Nonomura, 1974</xref>) and molecular identification.</p>
</sec>
<sec id="s2-2">
<title>Production of alpha-amylase inhibitor</title>
<p>Wheat bran was air-dried to constant weight and sterile basal medium (cornsteep liquor (0.4% v/v), glucose (1% w/v), (NH<sub>4</sub>)<sub>2</sub>HPO<sub>4</sub> (0.8% w/v), soyflour (0.4% w/v), peptone (1% w/v) at pH 8.3) was introduced and the set up was sterilized. <italic>Streptomyces</italic> inoculum was prepared in the following medium: [glucose (1%), soy flour (1%) and NaCl (0.25%)] (<xref ref-type="bibr" rid="B19">Oeding et al., 1980</xref>). The inoculum was introduced into sterile solid substrate and incubated at 28&#xb0;C &#xb1; 2&#xb0;C for production of &#x3b1;AI.</p>
</sec>
<sec id="s2-3">
<title>Optimisation of production conditions</title>
<p>Optimum conditions for the production of &#x3b1;AI were determined by the Response Surface Methodology (RSM). Three independent parameters; moisture content (%), pH and period of incubation (days) were varied at three levels (&#x2212;1, 0, &#x2b;1), using the Box&#x2013;Behnken design. The conditions were varied as follows: moisture content (65%, 70%, 75%), pH (6.0, 7.0, 8.0) and incubation period (5&#xa0;days, 10&#xa0;days, 15&#xa0;days). The variables were set up for 17 experimental runs (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Box&#x2014;Behnken design matrix for optimisation of pH, moisture content and incubation time for alpha&#x2013;amylase inhibitor production by actinomycetes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="4" align="center">Coded variables</th>
</tr>
<tr>
<th align="left">Trials</th>
<th align="left">pH</th>
<th align="left">Moisture</th>
<th align="left">Time</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">&#x2212;1</td>
<td align="left">&#x2212;1</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">&#x2b;1</td>
<td align="left">&#x2212;1</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">&#x2212;1</td>
<td align="left">&#x2b;1</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">&#x2b;1</td>
<td align="left">&#x2b;1</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">&#x2212;1</td>
<td align="left">0</td>
<td align="left">&#x2212;1</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">&#x2b;1</td>
<td align="left">0</td>
<td align="left">&#x2212;1</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">&#x2212;1</td>
<td align="left">0</td>
<td align="left">&#x2b;1</td>
</tr>
<tr>
<td align="left">8</td>
<td align="left">&#x2b;1</td>
<td align="left">0</td>
<td align="left">&#x2b;1</td>
</tr>
<tr>
<td align="left">9</td>
<td align="left">0</td>
<td align="left">&#x2212;1</td>
<td align="left">&#x2212;1</td>
</tr>
<tr>
<td align="left">10</td>
<td align="left">0</td>
<td align="left">&#x2b;1</td>
<td align="left">&#x2212;1</td>
</tr>
<tr>
<td align="left">11</td>
<td align="left">0</td>
<td align="left">&#x2212;1</td>
<td align="left">&#x2b;1</td>
</tr>
<tr>
<td align="left">12</td>
<td align="left">0</td>
<td align="left">&#x2b;1</td>
<td align="left">&#x2b;1</td>
</tr>
<tr>
<td align="left">13</td>
<td align="left">0</td>
<td align="left">0</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">14</td>
<td align="left">0</td>
<td align="left">0</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">15</td>
<td align="left">0</td>
<td align="left">0</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">16</td>
<td align="left">0</td>
<td align="left">0</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">17</td>
<td align="left">0</td>
<td align="left">0</td>
<td align="left">0</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-4">
<title>Extraction and purification</title>
<p>Recovery of the &#x3b1;AI from the <italic>Streptomyces</italic> culture on wheat bran was carried out according to the method of <xref ref-type="bibr" rid="B16">Mulimani and Supriya (1993)</xref> with modifications. At refrigerated temperature, using sodium phosphate buffer (20mM; pH 6.9), the extract was recovered in a centrifuge at 10,000&#xd7;g for 20&#xa0;min at 4&#xb0;C. The supernatant was decanted and stored as crude alpha-amylase inhibitor extract. Further purification was done by ammonium sulphate precipitation, overnight dialysis against extraction buffer at 4&#xb0;C and column chromatography using Sephadex G-100.</p>
</sec>
<sec id="s2-5">
<title>Assay</title>
<p>The presence of &#x3b1;AI in the extract was determined by the Dinitrosalicylic acid (DNSA) assay method described by <xref ref-type="bibr" rid="B2">Bernfeld (1955)</xref>. Readings were taken at 540&#xa0;nm using a UV-Visible Spectrophotometer.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<p>The isolate obtained was identified with a grey aerial mycelium, which appeared powdery with a firm adhesion to the agar surface. It could utilise all Carbon sources tested except inositol and could grow in the presence of NaCl up to 10%. Moreover, the isolate could grow in the presence of citrate but not in the presence of urea (<xref ref-type="table" rid="T2">Table 2</xref>). Molecular identification using the partial sequence of the 16S rRNA identified the isolate as <italic>Streptomyces xinghaiensis</italic> (GenBank accession number&#x2014;KY858944). The isolate was observed to fall into the same sub-clade with <italic>S. rubrus</italic> and <italic>S. tendae</italic> which have 98% and 97% similarity respectively with the isolate (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Characteristics of <italic>S.xinghaiensis</italic> AAI-2.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Test/Characteristics</th>
<th align="left">Result</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Colour of aerial mycelium</td>
<td align="left">Grey</td>
</tr>
<tr>
<td align="left">Appearance</td>
<td align="left">Powdery</td>
</tr>
<tr>
<td align="left">Colour on reverse side</td>
<td align="left">Cream</td>
</tr>
</tbody>
</table>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">Biochemical Characteristics</th>
</tr>
<tr>
<th colspan="2" align="left">Carbon Utilisation</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Inositol</td>
<td align="left">Negative</td>
</tr>
<tr>
<td align="left">Sucrose</td>
<td align="left">Positive</td>
</tr>
<tr>
<td align="left">Lactose</td>
<td align="left">Positive</td>
</tr>
<tr>
<td align="left">Maltose</td>
<td align="left">Positive</td>
</tr>
<tr>
<td align="left">Mannitol</td>
<td align="left">Positive</td>
</tr>
<tr>
<td align="left">Sorbitol</td>
<td align="left">Positive</td>
</tr>
<tr>
<td align="left">Growth In NaCl (2%&#x2013;10%)</td>
<td align="left">Positive</td>
</tr>
<tr>
<td align="left">Citrate utilisation</td>
<td align="left">Positive</td>
</tr>
<tr>
<td align="left">Urea hydrolysis</td>
<td align="left">Negative</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Effects of moisture content and pH on the activity of alpha&#x2013;amylase inhibitor.</p>
</caption>
<graphic xlink:href="fphar-14-1073754-g001.tif"/>
</fig>
<p>The activities obtained from each experimental trial were analysed, in order to obtain the optimum conditions of each environmental condition. The results are presented in <xref ref-type="fig" rid="F2">Figures 2</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>. These results were further iterated and the optimum values were predicted as shown in <xref ref-type="table" rid="T3">Table 3</xref>. The results show that optimum production conditions were obtained at 6.38&#x2013;6.87 pH, 70.7%&#x2013;73.4% moisture content and 8.5&#x2013;12&#xa0;days of incubation.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Effects of incubation period and pH on activity of alpha-amylase inhibitor.</p>
</caption>
<graphic xlink:href="fphar-14-1073754-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Phylogenetic tree showing the position of <italic>S. xinghaiensis</italic> among some closely related species.</p>
</caption>
<graphic xlink:href="fphar-14-1073754-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effects of incubation period and moisture content on the activity of AAI.</p>
</caption>
<graphic xlink:href="fphar-14-1073754-g004.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Predicted optimum values of the three variables.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Fermentation conditions</th>
<th colspan="5" align="center">Predicted optimised values</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">pH</td>
<td align="left">6.375710</td>
<td align="left">6.740031</td>
<td align="left">6.871774</td>
<td align="left">6.482091</td>
<td align="left">6.668138</td>
</tr>
<tr>
<td align="left">Moisture (%)</td>
<td align="left">70.73637</td>
<td align="left">72.02184</td>
<td align="left">72.46204</td>
<td align="left">73.00302</td>
<td align="left">73.42530</td>
</tr>
<tr>
<td align="left">Time (Days)</td>
<td align="left">11.93176</td>
<td align="left">9.19989</td>
<td align="left">8.51072</td>
<td align="left">9.75152</td>
<td align="left">8.80241</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>
<italic>Streptomyces xinghaiensis</italic> AAI2 isolated from soil was positive for starch, citrate and casein hydrolysis as well as the utilisation of many carbon sources for growth except inositol. These group of organisms are known to be able to degrade various kinds of substrates usually due to their ability to secrete a wide range of hydrolytic enzymes. This isolate was obtained from an environment characterized by active degradation of plant material; a factor that is capable of contributing to its ability to synthesize hydrolytic enzymes which are required for growth and absorption of nutrients. Citrate hydrolysis was not initially reported in this specie (<xref ref-type="bibr" rid="B31">Zhao et al., 2009</xref>; <xref ref-type="bibr" rid="B10">Kumar et al., 2012</xref>) as observed in this study. The partial sequence of the isolate bore 97% similarity to the complete genome of a known producer of alpha amylase inhibitor, <italic>S. tendae</italic> which is responsible for the production of the alpha amylase inhibitor named tendamistat (<xref ref-type="bibr" rid="B28">Vertesy et al., 1984</xref>). This similarity, in addition to information from the phylogenetic tree may infer relatedness in evolution and the presence of genes responsible for &#x3b1;AI production. Though <italic>S. xinghaiensis</italic> has never been identified as a producer of alpha amylase inhibitor, its metabolic potential tend towards being prolific, which is a characteristic of the genus. It has been shown from the draft genome sequence that this species can produce many new metabolic products. Of the 6,654 coding sequences contained in the genome sequence of <italic>S. xinghaiensis,</italic> 1,091 coding sequences are for proteins which do not match any proteins in the COG reference databases (<xref ref-type="bibr" rid="B32">Zhao and Yang, 2011</xref>). Furthermore, a study conducted between 2013 and 2017 discovered 167 new bioactive metabolites from 58 rare actinomycetes; confirming the metabolic dexterity of actinomycetes (<xref ref-type="bibr" rid="B23">Subramani and Sikpema, 2019</xref>).</p>
<p>Using the starch hydrolysis test, the isolate was putatively presented as amylase-producing. This ability formed the basis of its selection for &#x3b1;AI production since it has been opined that enzyme inhibitors may be found in the presence of the enzymes that they inhibit (<xref ref-type="bibr" rid="B26">Umezawa, 1973</xref>). &#x3b1;AI was produced by the isolate, using solid substrates which acted both as support for growth of the actinomycetes as well as the source of Carbon. The production of enzyme inhibitors in fermentation media is affected by factors including nature of the substrate, its moisture content, nutrient and mineral composition of the medium. Moreover, the importance of trace elements such as Manganese and Magnesium in the fermentation medium for enzyme inhibitor production has been emphasized. Wheat bran has been used as a support as well as nutrient source for the growth of many microorganisms and its success is attributed to the components of wheat bran which includes starch, protein and minerals (<xref ref-type="bibr" rid="B22">Rao et al., 2005</xref>; <xref ref-type="bibr" rid="B27">Verni et al., 2019</xref>). The ability of <italic>Streptomyces</italic> sp. to secrete extracellular enzymes such as hydrolases which are used to utilise both simple and complex molecules as nutrients makes them able to effectively utilise wheat bran as a solid substrate (<xref ref-type="bibr" rid="B7">Kapur et al., 2018</xref>). Wheat bran and the basal medium also contain nitrogen sources which have been found to have significant effects in the secondary metabolism of <italic>Streptomyces</italic> (<xref ref-type="bibr" rid="B3">Dilipkumar et al., 2013</xref>). In fact, cornsteep liquor and soybean flour were identified as Nitrogen sources which are necessary in the synthesis of inhibitor by <italic>Streptomyces</italic> (<xref ref-type="bibr" rid="B28">Vertesy et al., 1984</xref>). <xref ref-type="bibr" rid="B24">Tan <italic>et al.</italic> (2020)</xref> also supported the notion that the inclusion of soybean meal (which contains 49% crude protein, many important amino acids and microelements) in synthetic media has an advantage of enhancing metabolism in <italic>Streptomyces</italic>. Other important factors that determine product formation also include the pH, moisture content and duration of incubation.</p>
<p>The simplex search method of optimising conditions, using the data obtained from laboratory trials predicted the optimum production of &#x3b1;AI, as occurring between 9 and 12&#xa0;days of incubation. This claim is corroborated by the fact that the production of metabolites occurs after the exponential phase, which lasts for about 3&#x2013;7&#xa0;days in actinomycetes, depending on the environmental conditions and the species being used. Metabolite production which is initiated at this stage, is usually triggered by hyphal differentiation, stress or depletion of nutrients in the environment (<xref ref-type="bibr" rid="B30">Yague, et al., 2013</xref>; <xref ref-type="bibr" rid="B14">Manteca and Yag&#xfc;e, 2018</xref>). The &#x3b1;AI AI-3688 was formed in culture solution after a maximum of 10&#xa0;days. Research has reported other secondary metabolites produced by <italic>Streptomyces</italic> are produced in similar duration.</p>
<p>The importance of moisture in SSF and its effect on utilization of substrate for secondary metabolites formation is attributed to interference with physical properties of the solid particles (<xref ref-type="bibr" rid="B17">Nema et al., 2019</xref>). In fermentation, wheat bran absorbs liquid, leading to a swelling of the substrate particles, release and dissolution of the nutrients embedded in the substrate, resulting in better utilisation of the substrate by the microorganism (<xref ref-type="bibr" rid="B12">Manan and Webb, 2019</xref>). While increase in moisture beyond the optimum may reduce porosity of the substrate and limit oxygen and mass transfer, low moisture content however, causes reduction in nutrient solubility and a low degree of swelling (<xref ref-type="bibr" rid="B21">Pandey, 2003</xref>). In similar research optimising metabolite production by <italic>Streptomyces,</italic> <xref ref-type="bibr" rid="B8">Kar <italic>et al.</italic> (2010)</xref> found the optimum production of secondary metabolite using <italic>Streptomyces</italic> at 70% moisture content. Tylosin production by a strain of <italic>S. fradiae</italic> and oxytetracycline by <italic>S. rimosus</italic> and <italic>S. vendagensis</italic> in solid substrate were reported to be optimum at moisture content of about 70% (<xref ref-type="bibr" rid="B20">Okorie and Asagbra, 2008</xref>; <xref ref-type="bibr" rid="B9">Khaliq et al., 2009</xref>).</p>
<p>An initial pH of 6.4&#x2013;6.7 was predicted as optimum for the production of &#x3b1;AI using RSM. pH of the medium plays an important part in the physiology of the microorganism as it can affect the morphology of the organism as well as production of secondary metabolites (<xref ref-type="bibr" rid="B1">Bajaj and Singh, 2010</xref>). The results obtained favourably compares with the results of <xref ref-type="bibr" rid="B28">Vertesy <italic>et al.</italic> (1984)</xref> that discovered the production of an alpha&#x2013;amylase inhibitor at the pH values that favour the growth of <italic>Streptomyces.</italic>
</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In addition to the suitability of solid substrate (wheat bran) culture medium and other conditions for production of alpha amylase inhibitor by <italic>S. xinghaiensis</italic> AAI2, this novel producer of alpha amylase inhibitor within the <italic>Streptomyces</italic> genus, had optimum production conditions for pH, moisture content and incubation period at 6.4&#x2013;6.9, 71%&#x2013;73% and 9&#x2013;12&#xa0;days respectively.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/">https://www.ncbi.nlm.nih.gov/nuccore/</ext-link>, KY858944.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>AO conceptualized the research, supervised laboratory experiments, validated procedures and results obtained, corrected the initial draft and reviewed the final draft of the manuscript OF carried out laboratory experiments including choice of resources and software, wrote and corrected initial draft and involved in editing of the final draft YE was involved in project administration, assisted in the preparation and vetting of the manuscript CA advised on choice of computer software, supervised its utilisation and vetted the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajaj</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N. P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Production of xylanase from an alkalitolerant <italic>Streptomyces</italic> sp.7b under solid state fermentation, its purification and characterization</article-title>. <source>Appl. Biochem. Biotechnol.</source> <volume>162</volume> (<issue>6</issue>), <fpage>1804</fpage>&#x2013;<lpage>1818</lpage>. <pub-id pub-id-type="doi">10.1007/s12010-010-8960-x</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernfeld</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1955</year>). <article-title>Amylase &#x3b1; and &#x3b2;</article-title>. <source>Methods Enzym.</source> <volume>1</volume>, <fpage>149</fpage>. <pub-id pub-id-type="doi">10.1016/0076-6879(55)01021-5</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dilipkumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rajasimman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rajamohan</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Enhanced inulinase production by <italic>Streptomyces sp</italic> in solid state fermentation through statistical designs</article-title>. <source>Biotechnology</source> <volume>3</volume>, <fpage>509</fpage>&#x2013;<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1007/s13205-012-0112-2</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiNicolantonio</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Bhutani</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>O&#x27;Keefe</surname>
<given-names>J. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Acarbose: Safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes</article-title>. <source>Open Heart</source> <volume>2</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1136/openhrt-2015-000327</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rawat</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Recent developments in the synthesis of N&#x2010;heterocyclic compounds as &#x3b1;&#x2010;amylase inhibitors via in&#x2010;vitro and in&#x2010;silico analysis: Future drugs for treating diabetes</article-title>. <source>Chem. Sel.</source> <volume>7</volume> (<issue>28</issue>), <fpage>202201706</fpage>. <pub-id pub-id-type="doi">10.1002/slct.202201706</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holker</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Lenz</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Solid State Fermentation &#x2013; are there any biotechnological advantages?</article-title> <source>Curr. Opin. Microbiol.</source> <volume>8</volume>, <fpage>301</fpage>&#x2013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2005.04.006</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapur</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Solanki</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Role of microbial extracellular enzymes in the biodegradation of wastes</article-title>. <source>J. Pharm. Chem. Biol. Sci.</source> <volume>6</volume> (<issue>3</issue>), <fpage>237</fpage>&#x2013;<lpage>249</lpage>.</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Datta</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Optimization of thermostable &#x3b1;-amylase production by <italic>Streptomyces erumpens</italic> MTCC 7317 in solid state fermentation using cassava fibrous residue</article-title>. <source>Braz. Archives Biol. Technol.</source> <volume>53</volume> (<issue>2</issue>), <fpage>301</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1590/s1516-89132010000200008</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khaliq</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rashid</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ghauri</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Production of tylosin in solid-state fermentation by <italic>Streptomyces fradiae</italic> NRRL-2702 and its gamma-irradiated mutant (gamma-1)</article-title>. <source>Lett. Appl. Microbiol.</source> <volume>49</volume>, <fpage>635</fpage>&#x2013;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1111/j.1472-765X.2009.02720.x</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Anuradha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sarma</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Venkateshwarlu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kishan</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Screening, isolation, taxonomy and fermentation of an antibiotic producer <italic>Streptomyces xinghaiensis</italic> from soil capable of acting against linezolid resistant strains</article-title>. <source>Indian J. Exp. Biol.</source> <volume>50</volume>, <fpage>718</fpage>&#x2013;<lpage>728</lpage>.</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leite</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Filipe</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Recent advances in production of lignocellulolytic enzymes by solid-state fermentation of agro-industrial wastes</article-title>. <source>Curr. Opin. Green Sustain. Chem.</source> <volume>27</volume>, <fpage>100407</fpage>. <pub-id pub-id-type="doi">10.1016/j.cogsc.2020.100407</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manan</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Insights into physical characterization of solid state fermentation: From preliminary knowledge to practical application</article-title>. <source>J. Biotech. Res.</source> <volume>10</volume>, <fpage>271</fpage>&#x2013;<lpage>282</lpage>.</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manivasagan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Venkatesan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sivakumar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Actinobacterial enzyme inhibitors &#x2013; a review</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>41</volume> (<issue>2</issue>), <fpage>261</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.3109/1040841X.2013.837425</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manteca</surname>
<given-names>&#xc1;.</given-names>
</name>
<name>
<surname>Yag&#xfc;e</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Streptomyces differentiation in liquid cultures as a trigger of secondary metabolism</article-title>. <source>Antibiotics</source> <volume>7</volume> (<issue>2</issue>), <fpage>41</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics7020041</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Lauda</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>1975</year>). <article-title>Purification and properties of Phaseolamin, an inhibitor of alpha-amylase, from the kidney bean, <italic>Phaseolus vulgaris</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>25020</volume>, <fpage>8030</fpage>&#x2013;<lpage>8037</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(19)40811-9</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulimani</surname>
<given-names>V. H.</given-names>
</name>
<name>
<surname>Supriya</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Alpha amylase inhibitors in sorghum (Sorghum bicolor)</article-title>. <source>Plant Foods Hum. Nutr.</source> <volume>44</volume>, <fpage>261</fpage>&#x2013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1007/BF01088321</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nema</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Patnala</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Mandari</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kota</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Devarai</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Production and optimization of lipase using <italic>Aspergillus niger</italic> MTCC 872 by solid-state fermentation</article-title>. <source>Bull. Natl. Res. Cent.</source> <volume>43</volume>, <fpage>82</fpage>. <pub-id pub-id-type="doi">10.1186/s42269-019-0125-7</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nonomura</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>Key for classification and identification of 458 species of the streptomycetes included in the ISP</article-title>. <source>J. Ferment Technol.</source> <volume>52</volume>, <fpage>78</fpage>&#x2013;<lpage>92</lpage>.</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oeding</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pfaff</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Vertesy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Weidenmuller</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Alpha-amylase inhibitor from a Streptomycete and process for its preparation</article-title>. <source>CA1105404 A</source>.</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okorie</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Asagbra</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Oxytetracycline production by mix culture of <italic>Streptomyces rimosus</italic> and <italic>Streptomyces vendagensis</italic> in solid state fermentation of cassava peels</article-title>. <source>J. Ind. Res. Technol.</source> <volume>2</volume>, <fpage>43</fpage>&#x2013;<lpage>47</lpage>.</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Solid state fermentation</article-title>. <source>Biochem. Eng. J.</source> <volume>13</volume>, <fpage>81</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/s1369-703x(02)00121-3</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>K. C. S.</given-names>
</name>
<name>
<surname>Karanth</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Sattur</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Production of nigerloxin, an enzyme inhibitor, and a free radical scavenger, by <italic>Aspergillus niger</italic> using solid state fermentation</article-title>. <source>Process Biochem.</source> <volume>40</volume> (<issue>7</issue>), <fpage>2517</fpage>&#x2013;<lpage>2522</lpage>. <pub-id pub-id-type="doi">10.1016/j.procbio.2004.10.008</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sipkema</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Marine rare actinomycetes: A promising source of structurally diverse and unique novel natural products</article-title>. <source>Mar. Drugs</source> <volume>17</volume> (<issue>5</issue>), <fpage>249</fpage>. <pub-id pub-id-type="doi">10.3390/md17050249</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>L. T. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Goh</surname>
<given-names>B. H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Critical review of fermentation and extraction of anti-Vibrio compounds from <italic>Streptomyces</italic>
</article-title>. <source>Prog. Mircobes Mol. Bio1.</source> <volume>3</volume> (<issue>1</issue>), <fpage>a0000051</fpage>. <pub-id pub-id-type="doi">10.36877/pmmb.a0000051</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiwari</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Diversity and isolation of rare actinomycetes: An overview</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>39</volume> (<issue>3</issue>), <fpage>256</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.3109/1040841X.2012.709819</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umezawa</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1973</year>). <article-title>Chemistry of enzyme inhibitors of microbial origin</article-title>. <source>Pure Appl. Chem.</source> <volume>331</volume>, <fpage>129</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1351/pac197333010129</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rizzello</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Coda</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Fermentation biotechnology applied to cereal industry by-products: Nutritional and functional insights</article-title>. <source>Front. Nutr.</source> <volume>6</volume>, <fpage>42</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2019.00042</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Vertesy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tripier</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ritzel</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1984</year>). <source>Novel polypeptides with an &#x3b1;-amylase inhibiting action, a process for their preparation, their use and pharmaceutical products</source>. <comment>US4623714A</comment>.</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Dietary intervention with &#x3b1;-amylase inhibitor in white kidney beans added yogurt modulated gut microbiota to adjust blood glucose in mice</article-title>. <source>Front. Nutr.</source> <volume>8</volume>, <fpage>664976</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2021.664976</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yague</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lopes-Garcia</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Rioseras</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Manteca</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pre-sporulation stages of <italic>Streptomyces</italic> differentiation: State-of-the-art and future perspectives</article-title>. <source>Microbiol. Lett.</source> <volume>342</volume> (<issue>2</issue>), <fpage>79</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1111/1574-6968.12128</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Streptomyces xinghaiensis sp. nov., isolated from marine sediment</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source> <volume>59</volume>, <fpage>2870</fpage>&#x2013;<lpage>2874</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.009878-0</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Draft genome sequence of the marine sediment derived actinomycete <italic>Streptomyces xinghaiensis</italic> NRRL B24674T</article-title>. <source>J. Bacteriol.</source> <volume>193</volume> (<issue>19</issue>), <fpage>5543</fpage>. <pub-id pub-id-type="doi">10.1128/JB.05689-11</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>